I would suggest that Treagus is doing the work. Acadia is...

I would suggest that Treagus is doing the work. Acadia is smashing it because that have a drug in the market already and have just smashed more trial results for the same drug in different disorders. This will allow them to scale manufacturing and distribution channels already in place which is cash in the bank.

Neuren is yet to have a drug enter the market and the MC reflects this. I think Neuren have positioned the business extremely well - just need to land FDA approval and we are away. Some more water to go under the bridge yet, but I think the science is solid and we should expect good things. Just have to have to wait it out.